1 Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
2 Standard Chemotherapy + Mitazalimab, More Than 90% Effective In The Treatment Of Pancreatic Cancer! Oct 10, 2024
3 Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd Sep 05, 2024
Read More Medical New Research Shows Promise For Bone Marrow Transplant Recipient Patients To Reduce Treatment Side Effects! Nov 19, 2024
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Nov 17, 2024
